ACC Clinical Trials

1 recruiting

ACC Trials at a Glance

482 actively recruiting trials for acc are listed on ClinicalTrialsFinder across 6 cities in 77 countries. The largest study group is Not Applicable with 233 trials, with the heaviest enrollment activity in Houston, San Francisco, and Philadelphia. Lead sponsors running acc studies include University of California, San Francisco, Johns Hopkins University, and Johns Hopkins Bloomberg School of Public Health.

Treatments under study

About ACC Clinical Trials

Looking for clinical trials for ACC? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ACC trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ACC clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 482 trials

Recruiting

Natural History of Stroke: Cause and Development

Brain DiseaseVascular DiseasesIschemic Attack, Transient+2 more
National Institute of Neurological Disorders and Stroke (NINDS)4,000 enrolled3 locationsNCT00009243
Recruiting
Phase 1

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Adrenocortical Carcinoma (ACC)Carcinoma, AdrenocorticalCarcinoma, Adrenal Cortical+2 more
National Cancer Institute (NCI)32 enrolled1 locationNCT06487481
Recruiting
Phase 2

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Myelodysplastic/Myeloproliferative NeoplasmPolycythemia VeraPrimary Myelofibrosis+5 more
National Cancer Institute (NCI)62 enrolled30 locationsNCT06661915
Recruiting

Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome

Post-Acute COVID-19 Vaccination SyndromePostviral Fatigue
University of Bern200 enrolled1 locationNCT07400848
Recruiting
Phase 2

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Squamous Cell Carcinoma of the Head and NeckDrug TherapyOropharynx+2 more
National Cancer Institute (NCI)70 enrolled1 locationNCT06223568
Recruiting
Phase 3

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Opioid UseTobacco UsePolysubstance Abuse
Rutgers, The State University of New Jersey420 enrolled2 locationsNCT06033599
Recruiting
Not Applicable

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

KnowledgeVaccination UptakeInfluenza+1 more
Universiti Putra Malaysia351 enrolled4 locationsNCT06815250
Recruiting

Genomics and COVID-19 Vaccine Adverse Events

Vaccine Adverse Reaction
University of British Columbia6,325 enrolled1 locationNCT05212792
Recruiting
Not Applicable

Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services

StuntingEmpowermentAcceptability of Health Care+2 more
McGill University13,500 enrolled3 locationsNCT06362837
Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Healthy VolunteerTobacco Use DisorderMigraine+7 more
Yale University200 enrolled2 locationsNCT06624137
Recruiting
Phase 4

Beta-Adrenergic Modulation of Drug Cue Reactivity

Tobacco Use DisorderNicotine DependenceCigarette Smoking
University of Oklahoma80 enrolled1 locationNCT05587361
Recruiting
Not Applicable

Radiographic External Measurement Technique for TIVAP Placement

Vascular Access DeviceCatherization
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization120 enrolled1 locationNCT07549035
Recruiting
Phase 2Phase 3

Naltrexone for Overdose Prevention

Overdose Accidental
University of California, San Francisco100 enrolled1 locationNCT06633900
Recruiting
Not Applicable

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

Cigarette SmokingTobacco ProductsElectronic Nicotine Delivery Systems
University of Chicago46 enrolled1 locationNCT06395415
Recruiting
Not Applicable

Development and Evaluation of an Algorithm for Vascular Access Management

Peripheral Venous Access
Central Hospital, Nancy, France794 enrolled1 locationNCT05935228
Recruiting

National Bacterial Meningitis Study in Children and Newborns

MeningitisChildren, OnlyNeonatal Infection+5 more
Association Clinique Thérapeutique Infantile du val de Marne10,000 enrolled1 locationNCT04664569
Recruiting

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

MortalityPneumococcal InfectionsPneumococcal Conjugate Vaccine+1 more
Association Clinique Thérapeutique Infantile du val de Marne2,500 enrolled1 locationNCT04664556
Recruiting
Phase 2

Informing Oral Nicotine Pouch Regulations to Promote Public Health

Tobacco-Related Carcinoma
Ohio State University Comprehensive Cancer Center160 enrolled1 locationNCT06315881
Recruiting
Not Applicable

Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.

Frequency and Type of Medical Adhesive-Related Skin InjuryNPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate)Clinician Acceptability of New NPWT Drape+2 more
Global Biomedical Technologies, LLC300 enrolled6 locationsNCT06717308
Recruiting
Phase 2Phase 3

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Mucopolysaccharidosis IIIMPS IIIASanfilippo Syndrome+1 more
Ultragenyx Pharmaceutical Inc36 enrolled5 locationsNCT02716246